HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Beatrice Schuler-Thurner Selected Research
Beatrice Schuler-Thurner Research Topics
Disease
36
Neoplasms (Cancer)
01/2022 - 05/2002
33
Melanoma (Melanoma, Malignant)
06/2021 - 05/2002
6
Neoplasm Metastasis (Metastasis)
07/2021 - 08/2004
4
Uveal melanoma
01/2022 - 01/2017
3
Eosinophilia
03/2020 - 01/2013
2
HIV Infections (HIV Infection)
01/2020 - 11/2002
2
Lymphoma (Lymphomas)
08/2019 - 01/2018
2
Infections
01/2019 - 12/2018
2
Disease Progression
01/2017 - 08/2004
2
Inflammation (Inflammations)
01/2017 - 01/2013
1
Sclerosing Cholangitis
04/2022
1
Bites and Stings (Sting)
06/2021
1
Leukemia
08/2019
1
Skin Neoplasms (Skin Cancer)
01/2018
1
Merkel Cell Carcinoma
07/2017
1
Injection Site Reaction
04/2017
1
Sarcoidosis (Schaumann Disease)
01/2017
1
Infertility (Sterility)
01/2017
1
Cataract (Cataracts)
04/2014
1
Optic Nerve Diseases (Optic Neuropathy)
04/2014
1
Retinal Diseases
04/2014
1
Arterial Occlusive Diseases (Arterial Occlusive Disease)
04/2014
1
Nevus (Nevi)
04/2014
1
Cushing Syndrome
04/2014
1
Macular Degeneration (Age-Related Maculopathy)
04/2014
1
Uveitis
04/2014
1
Diabetic Retinopathy (Retinopathy, Diabetic)
04/2014
1
Mydriasis
04/2014
1
Pseudophakia
04/2014
1
Hemangioma (Angioma)
04/2014
1
Central Serous Chorioretinopathy
04/2014
1
Exanthema (Rash)
01/2013
1
Aseptic Meningitis
01/2013
1
Communicable Diseases (Infectious Diseases)
01/2010
1
Duchenne Muscular Dystrophy (Muscular Dystrophy, Becker)
01/2007
Drug/Important Bio-Agent (IBA)
16
Antigens
IBA
01/2022 - 05/2002
10
Peptides (Polypeptides)
IBA
04/2017 - 05/2002
9
Neoplasm Antigens (Tumor Antigens)
IBA
01/2022 - 04/2003
9
Vaccines
IBA
01/2022 - 04/2005
7
Messenger RNA (mRNA)
IBA
01/2022 - 01/2005
5
Chimeric Antigen Receptors
IBA
08/2019 - 10/2014
5
Proteins (Proteins, Gene)
FDA Link
01/2018 - 05/2002
4
RNA (Ribonucleic Acid)
IBA
01/2022 - 12/2015
4
Cytokines
IBA
05/2019 - 10/2014
3
Immune Checkpoint Inhibitors
IBA
01/2022 - 03/2020
3
Biomarkers (Surrogate Marker)
IBA
06/2021 - 01/2017
3
Ipilimumab
IBA
04/2017 - 01/2013
2
Interferons
IBA
06/2021 - 11/2002
2
Cancer Vaccines
IBA
03/2020 - 02/2011
2
MART-1 Antigen
IBA
01/2019 - 06/2005
2
T-Cell Antigen Receptors (T-Cell Receptor)
IBA
01/2019 - 08/2018
2
HLA-A1 Antigen (HLA A1 Antigen)
IBA
05/2008 - 11/2003
2
Chondroitin Sulfate Proteoglycans
IBA
04/2008 - 06/2007
2
Monophenol Monooxygenase (Tyrosinase)
IBA
06/2005 - 05/2005
2
HLA-DPw4 antigen
IBA
04/2005 - 01/2004
1
cyclic guanosine monophosphate-adenosine monophosphate
IBA
06/2021
1
Nectins
IBA
06/2021
1
talimogene laherparepvec
IBA
06/2021
1
Surface Antigens (Surface Antigen)
IBA
08/2018
1
Death Domain Receptors
IBA
01/2018
1
TNF-Related Apoptosis-Inducing Ligand
IBA
01/2018
1
A-factor (Streptomyces)
IBA
01/2018
1
Ligands
IBA
01/2018
1
Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)
IBA
01/2018
1
Small Interfering RNA (siRNA)
IBA
01/2018
1
Phosphatidylethanolamine Binding Protein
IBA
09/2017
1
raf Kinases
IBA
09/2017
1
Tumor Viral Antigens (Large T Antigen)
IBA
07/2017
1
Dinoprostone (PGE2)
FDA Link
04/2017
1
Interleukin-6 (Interleukin 6)
IBA
04/2017
1
Tumor Biomarkers (Tumor Markers)
IBA
01/2017
1
Indicators and Reagents (Reagents)
IBA
01/2017
1
Biological Products
IBA
01/2017
1
Transfer RNA (tRNA)
IBA
12/2015
1
HMW-MAA
IBA
12/2015
1
Autoantigens
IBA
12/2014
1
Monoclonal Antibodies
IBA
09/2014
1
Retinaldehyde (Retinal)
IBA
04/2014
1
Dexamethasone (Maxidex)
FDA Link
Generic
04/2014
1
iridal
IBA
04/2014
1
Fibrin
IBA
04/2014
1
Diphtheria Toxin
IBA
01/2014
1
Interleukin-2 (IL2)
IBA
01/2014
1
Pharmaceutical Preparations
IBA
01/2013
1
Exotoxins
IBA
04/2008
1
Immunotoxins (Immunotoxin)
IBA
04/2008
1
Cyclosporine (Ciclosporin)
FDA Link
Generic
04/2008
1
Immunoglobulin Fragments
IBA
04/2008
1
T-Lymphocyte Epitopes (Epitopes, T Lymphocyte)
IBA
06/2007
1
Chondroitin
IBA
06/2007
1
Membrane Glycoproteins (Membrane Glycoprotein)
IBA
06/2007
1
Proteoglycans (Proteoglycan)
IBA
06/2007
Therapy/Procedure
18
Immunotherapy
03/2020 - 10/2002
17
Therapeutics
04/2022 - 08/2004
2
Cell- and Tissue-Based Therapy (Cell Therapy)
08/2019 - 10/2014
2
Blood Component Removal (Apheresis)
09/2003 - 10/2002
1
Intralesional Injections
06/2021
1
Drug Therapy (Chemotherapy)
01/2018
1
Slit Lamp
04/2014
1
Aftercare (After-Treatment)
04/2008